Migrenin önlenmesi kılavuzu güncellendi

Amerikan Nöroloji Akademisi ve Amerikan Başağrısı Derneği migrenin önlenmesi kılavuzunu güncellediler…

 

Amerikan Noroloji Akademisi ve Amerikan Başağrısı Derneği migrenin önlenmesi kılavuzunu güncellediler…

KILAVUZ İÇİN TIKLAYIN…

 

The American Academy of Neurology and the American Headache Society have released updated guidelines on migraine prevention in Neurology.

Among the recommendations for prescription pharmacologic agents:

  • Most antiepileptic drugs (divalproex sodium, topiramate, sodium valproate), certain beta-blockers (metoprolol, propranolol, timolol), and one triptan (frovatriptan) are effective and should be offered to patients.
  • Certain antidepressants (amitriptyline, venlafaxine), other beta-blockers (atenolol, nadolol), and other triptans (naratriptan, zolmitriptan) are probably effective and should be considered.
  • Lamotrigine is not effective and should not be given.

Among the guidance on NSAIDs and complementary therapies:

  • Petasites (butterbur) is effective and should be offered.
  • Several NSAIDs (fenoprofen, ibuprofen, ketoprofen, naproxen), riboflavin, magnesium, feverfew, and histamine SC are probably effective and should be considered.

Montelukast is probably ineffective and should not be considered.